Publication | Closed Access

Quality of life in patients with metastatic breast cancer receiving either docetaxel or sequential methotrexate and 5-fluorouracil. A multicentre randomised phase III trial by the Scandinavian Breast Group

Metastatic Breast CancerBreast OncologyMedicinePhase Iii TrialBreast CancerPharmacotherapyCancer TreatmentOncologyRadiation OncologyScandinavian Breast Group